BioNTech SE (BNTX) posted a second-quarter net loss of 386.6 million euros compared to a net loss of 807.8 million euros, prior year. Loss per share was 1.60 euros, compared to a loss of 3.36 euros. Revenues were 260.8 million euros, compared to 128.7 million euros, last year.
BioNTech expects revenues for fiscal 2025 to be in the range of 1.7 - 2.2 billion euros, and revenue phasing primarily concentrated in the last three to four months, driving the full year revenue figure.
As part of the agreement with BMS, BioNTech expects to receive $1.5 billion in an upfront cash payment in the current year. BioNTech expects to receive $2.0 billion in total non-contingent anniversary cash payments from 2026 through 2028.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
For comments and feedback contact: editorial@rttnews.com
Business News
April 24, 2026 15:15 ET Economics news flow was relatively light this week even as the conflict in the Middle East continued, raising concerns for policymakers. In the U.S., spending data, initial jobless claims and pending home sales were the highlights. Business confidence in the biggest euro area economy was in focus in Europe. Inflation data from Japan gained attention in Asia.